To investigate the diagnostic value of f derived from IVIM technique and to correlate it with rCBV derived from DSC for the differentiation of residual/recurrent tumor from post-treatment change in patients with high-grade glioma.
Materials and Methods
Patients who underwent MR imaging with IVIM and DSC studies for evaluation of high-grade glioma after standard treatment were enrolled in this retrospective study. For qualitative analysis, the f and rCBV maps were interpreted as hypoperfused or hyperperfused in each parameter. Quantitative analysis was performed using ROI analysis in f and rCBV parameters. The lesions were divided into residual/recurrent tumor and post-treatment change groups.
Results
Nineteen patients with high-grade glioma were included. In qualitative analysis, the f-map shows higher sensitivity (100.0%) than rCBV map (92.3%), while the rCBV map shows higher specificity (100.0%) than the f-map (83.3%). In quantitative analysis, the optimal cutoff values of 1.19 for f and 1.06 for rCBV are shown to provide high diagnostic value with high sensitivity (91.7%) for both parameters but slightly higher specificity of rCBV (85.7%) than f (71.4%). The correlation between f and rCBV was good with ICC of 0.810.
Conclusion
The f value measured by IVIM technique, non-contrast perfusion technique, has high diagnostic performance and potential to be an alternative method to CBV measured by DSC for differentiation between residual/recurrent tumor and post-treatment change in patients with high-grade glioma.
van DijkenBRJvan LaarPJSmitsM, et al.Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques. J Magn Reson Imaging2019; 49(1): 11–22.
4.
van DijkenBRJvan LaarPJHoltmanGA, et al.Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis. Eur Radiol2017; 27(10): 4129–4144.
5.
PatelPBaradaranHDelgadoD, et al.MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis. Neuro Oncol2017; 19(1): 118–127.
6.
Le BihanD. What can we see with IVIM MRI?Neuroimage2019; 187: 56–67.
7.
PaschoalAMLeoniRFDos SantosAC, et al.Intravoxel incoherent motion MRI in neurological and cerebrovascular diseases. Neuroimage Clin2018; 20: 705–714.
8.
SigmundEEChoGYKimS, et al.Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med2011; 65(5): 1437–1447.
9.
BokachevaLKaplanJBGiriDD, et al.Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging2014; 40(4): 813–823.
10.
IimaMKataokaMSakaguchiR, et al.Intravoxel incoherent motion (IVIM) and non-Gaussian diffusion MRI of the lactating breast. Eur J Radiol Open2018; 5: 24–30.
11.
YamadaIAungWHimenoY, et al.Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology1999; 210(3): 617–623.
YoonJHLeeJMBaekJH, et al.Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr2014; 38(1): 110–116.
14.
JooILeeJMYoonJH, et al.Nonalcoholic fatty liver disease: intravoxel incoherent motion diffusion-weighted MR imaging-an experimental study in a rabbit model. Radiology2014; 270(1): 131–140.
15.
IchikawaSMotosugiUIchikawaT, et al.Intravoxel incoherent motion imaging of the kidney: alterations in diffusion and perfusion in patients with renal dysfunction. Magn Reson Imaging2013; 31(3): 414–417.
16.
ChandaranaHKangSKWongS, et al.Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest Radiol2012; 47(12): 688–696.
17.
GaingBSigmundEEHuangWC, et al.Subtype differentiation of renal tumors using voxel-based histogram analysis of intravoxel incoherent motion parameters. Invest Radiol2015; 50(3): 144–152.
18.
PangYTurkbeyBBernardoM, et al.Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med2013; 69(2): 553–562.
19.
DöpfertJLemkeAWeidnerA, et al.Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging. Magn Reson Imaging2011; 29(8): 1053–1058.
20.
SuhCHKimHSLeeSS, et al.Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging. Radiology2014; 272(2): 504–513.
21.
YamashitaKHiwatashiATogaoO, et al.Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme. J Magn Reson Imaging2016; 44(5): 1256–1261.
22.
ShimWHKimHSChoiCG, et al.Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion for Differentiating among Glioblastoma, Metastasis, and Lymphoma Focusing on Diffusion-Related Parameter. PLoS One2015; 10(7): e0134761.
23.
BisdasSKohTSRoderC, et al.Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: feasibility of the method and initial results. Neuroradiology2013; 55(10): 1189–1196.
24.
HuYCYanLFWuL, et al.Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: efficacy in preoperative grading. Sci Rep2014; 4: 7208.
25.
KikuchiKHiwatashiATogaoO, et al.Intravoxel Incoherent Motion MR Imaging of Pediatric Intracranial Tumors: Correlation with Histology and Diagnostic Utility. AJNR Am J Neuroradiol2019; 40(5): 878–884.
26.
DetskyJSKeithJConklinJ, et al.Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology. J Neurooncol2017; 134(2): 433–441.
27.
Le BihanDBretonELallemandD, et al.Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology1988; 168(2): 497–505.
28.
WirestamRBorgMBrockstedtS, et al.Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique. Acta Radiol2001; 42(2): 123–128.
29.
WuWCChenYFTsengHM, et al.Caveat of measuring perfusion indexes using intravoxel incoherent motion magnetic resonance imaging in the human brain. Eur Radiol2015; 25(8): 2485–2492.
30.
FederauCMeuliRO'BrienK, et al.Perfusion measurement in brain gliomas with intravoxel incoherent motion MRI. AJNR Am J Neuroradiol2014; 35(2): 256–262.
31.
FederauCO'BrienKMeuliR, et al.Measuring brain perfusion with intravoxel incoherent motion (IVIM): initial clinical experience. J Magn Reson Imaging2014; 39(3): 624–632.
32.
TogaoOHiwatashiAYamashitaK, et al.Differentiation of high-grade and low-grade diffuse gliomas by intravoxel incoherent motion MR imaging. Neuro Oncol2016; 18(1): 132–141.
33.
RydhögAPasternakOStåhlbergF, et al.Estimation of diffusion, perfusion and fractional volumes using a multi-compartment relaxation-compensated intravoxel incoherent motion (IVIM) signal model. Eur J Radiol Open2019; 6: 198–205.
34.
RydhögASvan OschMJLindgrenE, et al.Intravoxel incoherent motion (IVIM) imaging at different magnetic field strengths: what is feasible?Magn Reson Imaging2014; 32(10): 1247–1258.
LemkeAStieltjesBSchadLR, et al.Toward an optimal distribution of b values for intravoxel incoherent motion imaging. Magn Reson Imaging2011; 29(6): 766–776.
